Roffman Miller Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $412K | Sell |
|
|||||
|
2020
Q3 | $404K | Sell |
|
|||||
|
2020
Q2 | $474K | Buy |
|
|||||
|
2020
Q1 | $421K | Sell |
|
|||||
|
2019
Q4 | $576K | Sell |
|
|||||
|
2019
Q3 | $464K | Sell |
|
|||||
|
2019
Q2 | $417K | Buy |
|
|||||
|
2019
Q1 | $378K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $497K | Buy |
|
|||||
|
2018
Q2 | $431K | Sell |
|
|||||
|
2018
Q1 | $501K | Buy |
|
|||||
|
2017
Q4 | $484K | Sell |
|
|||||
|
2017
Q3 | $513K | Sell |
|
|||||
|
2017
Q2 | $482K | Sell |
|
|||||
|
2017
Q1 | $650K | Buy |
|
|||||
|
2016
Q4 | $550K | Sell |
|
|||||
|
2016
Q3 | $529K | Sell |
|
|||||
|
2016
Q2 | $736K | Sell |
|
|||||
|
2016
Q1 | $645K | Sell |
|
|||||
|
2015
Q4 | $749K | Sell |
|
|||||
|
2015
Q3 | $677K | Buy |
|
|||||
|
2015
Q2 | $724K | Sell |
|
|||||
|
2015
Q1 | $720K | Buy |
|
|||||
|
2014
Q4 | $652K | Sell |
|
|||||
|
2014
Q3 | $609K | Sell |
|
|||||
|
2014
Q2 | $603K | Sell |
|
|||||
|
2014
Q1 | $662K | Buy |
|
|||||
|
2013
Q4 | $624K | Buy |
|
|||||
|
2013
Q3 | $536K | Buy |
|
|||||
|
2013
Q2 | $517K | Buy |
|